As of 2025-05-16, the Fair Value of NLS Pharmaceutics AG (NLSP) is -13.34 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.62 USD, the upside of NLS Pharmaceutics AG is -925.22%.
With the market price of 1.62 USD and our fair value calculation, NLS Pharmaceutics AG (NLSP) is not a good investment. Investing in NLSP stocks now will result in a potential loss of 925.22%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -5.45 | -2.86 | -11.95 | -16.50 | -12.17 | -9.79 |
| YoY growth | -5.83% | 47.52% | -317.83% | -38.08% | 26.23% | -57.60% |
| Market Cap (mil) | 4.00 |
| P/E | |
| Forward P/E |
| EPS | -2.67 |
| Avg earnings growth rate | -57.60% |
| TTM earnings | -6.60 |